Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd

Future perspectives in melanoma research: meeting report from the “Melanoma Bridge”: Napoli, December 3rd–6th 2014

Published:2015-11-30 Issue:1 Volume:13 Page:
ISSN:1479-5876
Container-title:Journal of Translational Medicine
language:en
Short-container-title:J Transl Med

Author:

Ascierto Paolo A.,Atkins Michael,Bifulco Carlo,Botti Gerardo,Cochran Alistair,Davies Michael,Demaria Sandra,Dummer Reinhard,Ferrone Soldano,Formenti Silvia,Gajewski Thomas F.,Garbe Claus,Khleif Samir,Kiessling Rolf,Lo Roger,Lorigan Paul,Arthur Grant Mc,Masucci Giuseppe,Melero Ignacio,Mihm Martin,Palmieri Giuseppe,Parmiani Giorgio,Puzanov Igor,Romero Pedro,Schilling Bastian,Seliger Barbara,Stroncek David,Taube Janis,Tomei Sara,Zarour Hassane M.,Testori Alessandro,Wang Ena,Galon Jérôme,Ciliberto Gennaro,Mozzillo Nicola,Marincola Francesco M.,Thurin Magdalena

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1186/s12967-015-0736-1

Reference149 articles.

1. Azimi F, Scolyer RA, Rumcheva P, et al. Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. J Clin Oncol. 2012;30(21):2678–83.

2. Marchand M, van Baren N, Weynants P, et al. Tumor regressions observed in patients with metastatic melanoma treated with an antigenic peptide encoded by gene MAGE-3 and presented by HLA-A1. Int J Cancer. 1999;80(2):219–30.

3. Connerotte T, Van Pel A, Godelaine D, et al. Functions of anti-MAGE T-cells induced in melanoma patients under different vaccination modalities. Cancer Res. 2008;68(10):3931–40.

4. Schwartzentruber DJ, Lawson DH, Richards JM, et al. gp100 peptide vaccine and interleukin-2 in patients with advanced melanoma. N Engl J Med. 2011;364(22):2119–27.

5. Oshita C, Takikawa M, Kume A, et al. Dendritic cell-based vaccination in metastatic melanoma patients: phase II clinical trial. Oncol Rep. 2012;28(4):1131–8.

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The BRAF V600E Mutation Detection by quasa Sensitive Real-Time PCR Assay in Northeast Romania Melanoma Patients;Applied Sciences;2021-10-13

2. A novel immune checkpoint-related seven-gene signature for predicting prognosis and immunotherapy response in melanoma;International Immunopharmacology;2020-10

3. Effect of ABT-888 on the apoptosis, motility and invasiveness of BRAFi-resistant melanoma cells;International Journal of Oncology;2018-06-27

4. Blockade of MIF–CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma;Frontiers in Immunology;2018-05-23

5. Interfering with MIF-CD74 signalling on macrophages and dendritic cells with a peptide-based approach restores the immune response against metastatic melanoma;2018-01-16